Index of reports
> Cases with Neutropenia (91)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 91 Next >>
Possible Xeloda side effects in 62 year old male
Reported by a physician from Poland on 2012-08-23
Patient: 62 year old male
Reactions: Kwashiorkor, Carcinoembryonic Antigen Increased, Increased Appetite, Nausea, Anaemia, General Physical Health Deterioration, Palmar-Plantar Erythrodysaesthesia Syndrome, Ascites, Apathy, Death, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-14
Xeloda
Indication: Product Used FOR Unknown Indication
Start date: 2010-12-14
Other drugs received by patient: Diaprel MR
Possible Xeloda side effects in female
Reported by a physician from Switzerland on 2012-08-22
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Abdominal Pain, Vomiting, Anaemia, Lymphopenia, Pyrexia, Diarrhoea, Small Intestinal Perforation, Sepsis, Hypoalbuminaemia, Neutropenia, Enterocolitis, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Herceptin
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: female, weighing 43.6 kg (95.9 pounds)
Reactions: Stomatitis, White Blood Cell Disorder, Electrolyte Imbalance, Neutropenia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-13
Patient:
Reactions: Abdominal Pain, Blood Bilirubin Increased, Thrombosis, Anal Examination Abnormal, Hypokalaemia, Fatigue, Proteinuria, Abdominal Distension, Decreased Appetite, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Hyponatraemia, Small Intestinal Obstruction, Hypophosphataemia, Diarrhoea, Alopecia, Dehydration, Neutropenia, Hypertension, Vascular Access Complication
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Dosage: given on day 1
Indication: Colorectal Cancer Metastatic
Irinotecan Hydrochloride and Irinotecan Hydrochloride
Dosage: given on day 1
Indication: Colorectal Cancer Metastatic
Xeloda
Dosage: 1000 mg/m2 twice daily for age below 65 years,750 mg/m2 twice daily for age above 65 years
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from Italy on 2012-08-08
Patient:
Reactions: Stomatitis, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Liver Disorder, Mucosal Inflammation, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Indication: Breast Cancer Metastatic
Xeloda
Indication: Breast Cancer Metastatic
Possible Xeloda side effects in
Reported by a physician from Spain on 2012-08-07
Patient:
Reactions: Abdominal Pain, Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Death, Fatigue, Diarrhoea, Neutropenia, Hypertension, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Blinded Sorafenib and Blinded Sorafenib
Administration route: Oral
Indication: Breast Cancer
Xeloda
Dosage: drug was used for 14 days every 21 days.
Administration route: Oral
Indication: Breast Cancer
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-08-06
Patient:
Reactions: Vomiting, Anaemia, Pulmonary Embolism, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Peripheral Sensory Neuropathy, Mucosal Inflammation, Diarrhoea, Proteinuria, Neutropenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Dosage: fluorouracil based regimen
Indication: Colorectal Cancer Metastatic
Avastin
Dosage: capecitabine-based regimen
Fluorouracil
Dosage: on day 1
Fluorouracil
Indication: Colorectal Cancer Metastatic
Irinotecan Hydrochloride
Dosage: dose: 150/180 mg/m2 on day 1
Indication: Colorectal Cancer Metastatic
Leucovorin Calcium
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Oxaliplatin
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Xeloda
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in female
Reported by a physician from Japan on 2012-07-30
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Vomiting, Incontinence, Disseminated Intravascular Coagulation, Platelet Count Decreased, Acute Hepatic Failure, Neutropenia, Altered State of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Meropenem
Dosage: dosage is uncertain.
Indication: Infection Prophylaxis
Start date: 2011-10-14
End date: 2011-10-18
Xeloda
Administration route: Oral
Indication: Rectal Cancer
Start date: 2011-08-29
End date: 2011-09-11
Xeloda
Administration route: Oral
Start date: 2011-09-26
End date: 2011-10-09
Other drugs received by patient: Aloxi; Dexamethasone Sodium Phosphate; Ganaton; Oxaliplatin; Famotidine; Pydoxal
Possible Xeloda side effects in 80 year old female
Reported by a physician from Lebanon on 2012-07-26
Patient: 80 year old female
Reactions: Skin Exfoliation, Pancytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Diarrhoea, Skin Discolouration, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-07-24
Patient:
Reactions: Neuropathy Peripheral, Diarrhoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Indication: Colorectal Cancer
Irinotecan Hydrochloride
Indication: Colorectal Cancer
Oxaliplatin
Indication: Colorectal Cancer
Xeloda
Indication: Colorectal Cancer
Possible Xeloda side effects in male
Reported by a physician from Sweden on 2012-07-23
Patient: male
Reactions: Gastrointestinal Disorder, Metabolic Disorder, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin Hydrochloride
Dosage: last dose prior to sae 23/may/2012, cumulative dose 200 mg
Indication: Gastric Cancer
Start date: 2012-05-02
Oxaliplatin
Dosage: last dose prior to sae 23/may/2012, cumulative dose 500 mg
Indication: Gastric Cancer
Start date: 2012-05-02
Xeloda
Dosage: last dose prior to sae 3/jun/2012, cumulative dose 73600 9units not provided)
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-05-02
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female
Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Xeloda
Indication: Breast Cancer
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-11
Patient:
Reactions: Weight Decreased, Thrombosis, Pruritus, Hypokalaemia, Fatigue, Depression, Thrombocytopenia, Alanine Aminotransferase Abnormal, Blood Antidiuretic Hormone Abnormal, Dyspnoea, Nausea, Lymphopenia, Haemoglobin Abnormal, Hyponatraemia, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Diarrhoea, Embolism, Blood Alkaline Phosphatase Abnormal, Dehydration, Neutropenia, Leukopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on days 1-14
Administration route: Oral
Indication: Breast Cancer Metastatic
Xeloda
Dosage: beginning on day 8 and continuing to day 21 (total of 14 days)
Administration route: Oral
Indication: Breast Cancer Metastatic
Possible Xeloda side effects in female
Reported by a individual with unspecified qualification from United Kingdom on 2012-07-11
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Dehydration, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: date of last dose prior to sae: 21/jun/2012
Indication: Gastric Cancer
Start date: 2012-05-10
Cisplatin
Dosage: date of last dose prior to sae: 21/jun/2012
Indication: Gastric Cancer
Start date: 2012-05-10
Epirubicin Hydrochloride
Dosage: date of last dose prior to sae: 21/jun/2012
Indication: Gastric Cancer
Start date: 2012-05-10
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-05-10
Other drugs received by patient: Ranitidine; Milk Thistle; COD Liver OIL; Chondroitin + Glucosamine
Possible Xeloda side effects in 67 year old female
Reported by a physician from France on 2012-07-05
Patient: 67 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Neutropenia, Purpura, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temodal
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-30
End date: 2012-05-03
Xeloda
Start date: 2012-05-20
Xeloda
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-20
End date: 2012-05-03
Possible Xeloda side effects in 67 year old female
Reported by a physician from France on 2012-06-29
Patient: 67 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Haemoglobin Decreased, Condition Aggravated, Neutropenia, Purpura, Thrombocytopenia, Oral Mucosa Erosion, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temodal
Dosage: 250 mg, qd, po
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-30
End date: 2012-05-03
Xeloda
Dosage: 800 mg, bid, po
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-05-20
Xeloda
Dosage: 800 mg, bid, po
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-20
End date: 2012-05-03
Possible Xeloda side effects in 67 year old female
Reported by a physician from France on 2012-06-27
Patient: 67 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Mouth Haemorrhage, Purpura, Neutropenia, Thrombocytopenia, Oral Mucosa Erosion, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temodal
Dosage: 200 mg;qd;po
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-30
End date: 2012-05-03
Xeloda
Dosage: 800 mg;bid;po
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-20
End date: 2012-05-21
Possible Xeloda side effects in 67 year old female
Reported by a physician from France on 2012-06-26
Patient: 67 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Purpura, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temodal
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-30
End date: 2012-05-03
Xeloda
Administration route: Oral
Indication: Pancreatic Neoplasm
Start date: 2012-04-20
End date: 2012-05-21
Possible Xeloda side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-22
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Breast Cancer
Start date: 2012-02-08
Cisplatin
Indication: Gastric Cancer
Start date: 2012-02-08
Cisplatin
Start date: 2012-02-29
Cisplatin
Start date: 2012-02-29
Emend
Administration route: Oral
Start date: 2012-02-08
End date: 2012-03-02
Emend
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Herceptin
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-29
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Other drugs received by patient: Iperten; Allopurinol; Xenetix; Lovenox; Magnesium Sulfate; Cordarone; Bisoprolol Fumarate and Hydrochlorothiazide; Lorazepam; Potassium Chloride; Nexium; Acetaminophen; Tramadol HCL; Zofran
Possible Xeloda side effects in female
Reported by a physician from Poland on 2012-06-22
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Weight Decreased, Metastases To Liver, Tumour Marker Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, General Physical Health Deterioration, Oedema Peripheral, Nail Disorder, Neutropenia, Thrombocytopenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Docetaxel
Indication: Breast Cancer
Start date: 2010-06-25
End date: 2010-10-24
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-06-25
End date: 2011-01-04
Other drugs received by patient: Tamoxifen Citrate; Anastrozole; Vinorelbine; Exemestane; Zoladex
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-06-20
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Sepsis, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose prior to sae: 21/may/2012
Indication: Breast Cancer Metastatic
Start date: 2011-11-07
Vinorelbine Tartrate
Dosage: last dose prior to sae: 29/may/2012
Indication: Breast Cancer Metastatic
Start date: 2011-11-07
Xeloda
Dosage: last dose prior to sae: 29/may/2012
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-11-07
Other drugs received by patient: Insulin
Possible Xeloda side effects in 54 year old female
Reported by a physician from Poland on 2012-06-19
Patient: 54 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Weight Decreased, Tumour Marker Increased, Metastases To Liver, General Physical Health Deterioration, Palmar-Plantar Erythrodysaesthesia Syndrome, Oedema Peripheral, Nail Disorder, Neutropenia, Thrombocytopenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Docetaxel
Indication: Breast Cancer
Start date: 2010-06-25
End date: 2010-10-24
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-06-25
Other drugs received by patient: Exemestane; Anastrozole; Vinorelbine; Tamoxifen; Zoladex
Possible Xeloda side effects in 77 year old female
Reported by a physician from France on 2012-06-15
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Start date: 2012-02-29
Cisplatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-08
End date: 2012-02-29
Emend
Dosage: on day 1, 2 and 3 of 14 day cycle
Indication: Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Herceptin
Start date: 2012-02-29
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Other drugs received by patient: Iperten; Nexium; Allopurinol; Xenetix; Bisoprolol Fumarate and Hydrochlorothiazide; Lovenox; Kaleorid LP; Zofran; Lorazepam; Acetaminophen; Tramadol HCL; Cordarone
Possible Xeloda side effects in male
Reported by a physician from Sweden on 2012-06-12
Patient: male
Reactions: Gastrointestinal Disorder, Metabolic Disorder, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin Hydrochloride
Dosage: last dose prior to sae 23/may/2012
Indication: Gastric Cancer
Start date: 2012-05-02
Oxaliplatin
Dosage: last dose prior to sae 23/may/2012
Indication: Gastric Cancer
Start date: 2012-05-02
Xeloda
Dosage: last dose prior to sae 3/jun/2012
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-05-02
Other drugs received by patient: Clindamycin
Possible Xeloda side effects in female
Reported by a individual with unspecified qualification from Greece on 2012-06-04
Patient: female
Reactions: Vomiting, Hypersensitivity, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Neurotoxicity, Fatigue, Diarrhoea, Neutropenia
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from China on 2012-05-29
Patient:
Reactions: Neurotoxicity, Vomiting, Nausea, Diarrhoea, Neutropenia, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Oxaliplatin
Indication: Gastric Cancer
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from Spain on 2012-05-28
Patient:
Reactions: Paronychia, Dermatitis Acneiform, Conjunctivitis, Pulmonary Embolism, Palmar-Plantar Erythrodysaesthesia Syndrome, Blepharitis, Mucosal Inflammation, Diarrhoea, Neutropenia, Myocardial Infarction, Eye Disorder, Deep Vein Thrombosis, Keratitis
Drug(s) suspected as cause:
Cetuximab
Dosage: 2-hr infusion followed by 250 mg/m2.
Indication: Colorectal Cancer
Cetuximab
Dosage: weekly dose.
Xeloda
Administration route: Oral
Indication: Colorectal Cancer
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from United States on 2012-05-28
Patient:
Reactions: Pain, Mental Status Changes, Pulmonary Embolism, Constipation, Neuropathy Peripheral, Fatigue, Dyspepsia, Oral Candidiasis, Oedema, Decreased Appetite, Hypovolaemia, Blood Alkaline Phosphatase Increased, Vomiting, Dysphagia, Nausea, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Brachial Plexopathy, Anxiety, Mucosal Inflammation, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Neutropenia
Drug(s) suspected as cause:
Paclitaxel
Dosage: on days 1-8
Indication: Breast Cancer Metastatic
Xeloda
Dosage: on days 1-15
Administration route: Oral
Indication: Breast Cancer Metastatic
Possible Xeloda side effects in
Reported by a physician from Greece on 2012-05-24
Patient:
Reactions: Large Intestine Perforation, Nausea, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Febrile Neutropenia, Mucosal Inflammation, Fatigue, Diarrhoea, Alopecia, Neutropenia, Thrombocytopenia, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Dosage: on day 1 and every 2 wks
Avastin
Dosage: on day 1 and every 3 wks
Indication: Colorectal Cancer Metastatic
Fluorouracil
Dosage: given per day
Fluorouracil
Dosage: 22hrs continous infusion day 1 and 2 per day
Indication: Colorectal Cancer Metastatic
Irinotecan Hydrochloride
Dosage: on day 1
Irinotecan Hydrochloride
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Leucovorin Calcium
Dosage: on day 1 and 2
Indication: Colorectal Cancer Metastatic
Xeloda
Dosage: 1-14 days
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in female
Reported by a physician from Slovenia on 2012-05-23
Patient: female, weighing 64.0 kg (140.8 pounds)
Reactions: Vomiting, Sepsis, Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Euthyrox; Naklofen DUO; Haldol; Nexium; Reglan
Page 1 Next >>
|